Sign In
Buy FREQ
$0.300
+0 (+0%)
At Close: Feb 02, 2024
Frequency Therapeutics Provides Business Updates and Reports First Quarter 2021 Financial Results
07:30am, Thursday, 13'th May 2021
LEXINGTON, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage cause
Analysts Estimate Frequency Therapeutics, Inc. (FREQ) to Report a Decline in Earnings: What to Look Out for
03:46pm, Thursday, 06'th May 2021
Frequency Therapeutics, Inc. (FREQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Frequency Therapeutics: A Look At What's Next After A Disappointing Data Readout
10:10pm, Tuesday, 20'th Apr 2021
I previously covered Frequency Therapeutics after the company had initiated a Phase 2a trial on the heels of a positive Phase 1/2 trial. This Phase 2a trial featured about three times more patients bu
Are Disappointing Results an Opportunity for Frequency Therapeutics Investors?
07:43am, Friday, 16'th Apr 2021
A risky path lies ahead for the clinical-stage biotech, which saw disappointing results for FX-322 in March 2021. Can management learn from its mistakes?
Frequency Therapeutics Expands its Clinical Development Team, Adding Expertise in Inner Ear Physiology and Translational Science
07:00am, Tuesday, 13'th Apr 2021
LEXINGTON, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage cause
Frequency Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
07:00am, Friday, 09'th Apr 2021
WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused b
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Frequency Therapeutics, Inc. - FREQ
02:15am, Tuesday, 06'th Apr 2021
NEW YORK, April 6, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ: FREQ). Such investors a
LOS ANGELES, April 2, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Frequency Therapeuti
LOS ANGELES--(BUSINESS WIRE)---- $FREQ #FREQ--INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Frequency Therapeutics, Inc.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Frequency Therapeutics, Inc. - FREQ
11:26pm, Wednesday, 31'st Mar 2021
New York, New York--(Newsfile Corp. - March 31, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ: FREQ). Such
LOS ANGELES--(BUSINESS WIRE)---- $FREQ #FREQ--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Frequency Therapeutics, Inc.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Frequency Therapeutics, Inc. - FREQ
03:30am, Tuesday, 30'th Mar 2021
NEW YORK, March 30, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ: FREQ). Such investor
Frequency Therapeutics, Inc. (FREQ) Reports Q4 Loss, Lags Revenue Estimates
06:09pm, Monday, 29'th Mar 2021
Frequency Therapeutics, Inc. (FREQ) delivered earnings and revenue surprises of 0.00% and -2.93%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for th
Is the Frequency Therapeutics Recovery a Dead Cat Bounce?
10:16am, Wednesday, 24'th Mar 2021
Frequency Therapeutics Inc. (NASDAQ: FREQ) shares were absolutely crushed in Tuesday's session.
Frequency Therapeutics Plunges On Study Setback: Technical Levels To Watch
03:20pm, Tuesday, 23'rd Mar 2021
Frequency Therapeutics Inc. (NASDAQ: FREQ) stock imploded Tuesday amid the company's announcement that its interim FX-322 Phase 2a results showed that four weekly injections did not demonstrate impr
